The extent of cellular proliferation, which is investigated through Ki-67 immunoreactivity, has been studied as a prognosis indicator in several malignant neoplasms and results showed its relationship with the size of tumor and its clinical course (Al Moundhri et al., 2005; Lindboe et al., 2003). The gene discussed is MKI67; the disease is cancer.